Company · Healthtech & Bio

Bexen Bioservices

bexen.com ↗ ·Hernani ·Other

Bexen Bioservices is a biotech services business operating four biorepositories for ultra-low-temperature (-20°C to -100°C) storage of biological samples and thermolabile drugs, and manufactures ISO 7 cleanroom single-use bags for bioprocessing. It is not a VC-backed startup: it is a brand of the Oiarso S.Coop cooperative, part of Spain's 45+ year old MONDRAGON Corporation group, based in the Basque Country. No founders, investors, or funding rounds exist for this entity since it is a cooperative division rather than an independent venture-funded company.

Founded

2019

Founders

News

Rounds

SectorsBiotechnology, Biorepository / Cold Chain Services, Bioprocessing Manufacturing Start-up MapHealthtech & Bio › Biologics manufacturing & CDMO

Profile updated 28 Jul 2026

Founders

No names on record yet.

Global models 5

Resilience (National Resilience Inc.)

United States · resilience.com ↗

Venture-backed biomanufacturing/bioprocessing CDMO offering large-scale, tailor-made process and fill-finish services similar to Bexen Bioservices' contract bioprocessing model.

$2.0B+Comparable

Cellares

United States · cellares.com ↗

VC-funded automated cell/gene-therapy manufacturing platform, matching Bexen's biotech bioprocessing and single-use systems focus.

$500M+Comparable

Cryoport

United States · cryoport.com ↗

Cold-chain logistics and GMP biorepository services for biopharma samples, directly comparable to Bexen Bioservices' biorepository storage business.

$300M+Comparable

Single Use Support

Austria · www.susupport.com ↗

Manufactures single-use bags and freeze-thaw/cold-chain platforms for biopharma, an extremely close model match to Bexen's single-use bioprocessing bag manufacturing.

$150MComparable

Sexton Biotechnologies

United States · sextonbio.com ↗

VC-backed biopreservation and cold-chain products for cell and gene therapy, paralleling Bexen's drug/sample preservation services.

$25MComparable

Investors

No investors found yet.

Funding rounds

No announced rounds on record.

News & media

No coverage on record yet.